Form 4: BeOne Medicines Director Plans Future Share Gift

BeOne Medicines Ltd. Director Xiaodong Wang reported a pre-planned gift of 148,096 ordinary shares effective September 9, 2025, under a Rule 10b5-1 plan.

Summary

• Xiaodong Wang, a Director, 10% Owner, and Chair of the Scientific Advisory Board of BeOne Medicines Ltd. (ONC), reported a disposition of 148,096 ordinary shares.
• The transaction is a bona fide gift, exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
• The gift is scheduled to occur on September 9, 2025, and was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following this planned transaction, Wang will directly own 5,006,674 ordinary shares.
• Wang also has indirect beneficial ownership of 1,025,063 ordinary shares held by a family trust, 3,953,100 ordinary shares held by Wang Investment LLC, and 50 ordinary shares held by his spouse. Wang disclaims beneficial ownership for the shares held by the family trust and Wang Investment LLC.

Sentiment

Score: 5

Explanation: A gift transaction is a personal financial planning event for an insider, generally having a neutral impact on the company's operational or financial outlook. The pre-planned nature under Rule 10b5-1 adds transparency.

Positives

• The transaction is a bona fide gift, which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and structured approach to personal financial management.

Negatives

• A reduction in direct shareholdings, even through a gift, represents a decrease in the insider's direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Indirect beneficial ownership of 1,025,063 shares is held by a family trust, with the Reporting Person disclaiming beneficial ownership.
• Indirect beneficial ownership of 3,953,100 shares is held by Wang Investment LLC, where 99% of the interest is owned by two grantor retained annuity trusts, and the Reporting Person's wife is a trustee. The Reporting Person disclaims beneficial ownership.
• Indirect beneficial ownership of 50 shares is held by the spouse of the Reporting Person.

Stakeholder Impact

• Shareholders: Minimal direct impact on the company's operational or financial performance. Represents a change in an insider's personal holdings.
• Reporting Person: Reduces direct share ownership but is part of a pre-planned personal financial strategy.

Key Dates

Keywords

BeOne Medicines, ONC, Xiaodong Wang, Form 4, insider transaction, gift of shares, beneficial ownership, Rule 10b5-1, director, 10% owner